Transcranial Direct Current Stimulation in Acute Ischemic Stroke Treatment

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

February 10, 2024

Conditions
Stroke
Interventions
DEVICE

Soterix Medical 1X1 tDCS stimulator (active C-tDCS)

Patients will be randomized to active treatment (C-tDCS) vs sham stimulation in a 3:1 ratio. There will be 6 dose tiers, reflecting increasing intensity and duration of stimulation: Tier 1 - 1 mA, single 20 - min cycle; Tier 2- 2 mA, single 20 min cycle; Tier 3 - 1 mA, 2 cycles of 20 min/20 min off; Tier 4- 2 mA, 2 cycles of 20 min/20 min off; Tier 5 - 1 mA, 3 cycles of 20 min/20 min off; Tier 6 - 2 mA, 3 cycles of 20 min/20 min off.

DEVICE

Soterix Medical 1X1 tDCS stimulator (sham stimulation)

Patients will be randomized to active treatment (C-tDCS) vs sham stimulation in a 3:1 ratio. Patients in the sham stimulation arm at all the tiers will have the headgear and electrodes in place, and the switch for sham stimulation will be on, i.e. no prolonged electrical stimulation will be delivered.

Trial Locations (1)

12000

Department of Neurology, General University Hospital in Prague, Prague

All Listed Sponsors
lead

General University Hospital, Prague

OTHER